Confirmation of Hereditary Tyrosinemia Type 1 in Neonatal Stage Using Spectrophotometric Microassay Based on the Determination of Succinylacetone Level in Dried-blood Spots

Hereditary Tyrosinemia Type 1 (HT1) is a metabolic disorder below to the class of autosomal recessive inheritance caused by the dearth of enzyme fumaryl acetoacetase the last enzyme in the tyrosine catabolic pathway . Affected individuals show increased tyrosine and succinyl acetone concentration (SA) in blood. Patients also excrete increased concentration of SA in urine. The disorder is characterized by progressive liver disease and renal tubular defects with accompanying hypophosphatemic rickets. Symptoms of HT1 usually appear in the first few months of life and include failure to gain weight and grow at the expected rate, diarrhea, vomiting, yellowing of the skin and whites of the eyes (jaundice). It may also lead to liver and kidney failure and an increased risk of liver cancer. Liver transplantation is the only effective treatment for hereditary tyrosinemia type 1. In the present study, Succinyl Acetone is measured by using its inhibitory property on d-aminolaevulinate dehydratase enzyme for the diagnosis of HT1 in dried blood spots. Gautam Kumar*, Akanksha Sharma* and Shivam P S Y